Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Alterations of signaling pathways in response to chemical perturbations used to measure mRNA decay rates in yeast.

Eshleman N, Luo X, Capaldi AP, Buchan R.

RNA. 2019 Oct 10. pii: rna.072892.119. doi: 10.1261/rna.072892.119. [Epub ahead of print]

PMID:
31601735
2.

Primary care doctor and nurse utilisation rates for billed consultations across the Comprehensive Care Primary Health Organisation.

Baldwin JN, Garrett N, Larmer PJ, Murray C, Evans R, Buchan R, Neville S.

N Z Med J. 2019 Jul 12;132(1498):79-89.

PMID:
31295240
3.

Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators.

Corden B, Jarman J, Whiffin N, Tayal U, Buchan R, Sehmi J, Harper A, Midwinter W, Lascelles K, Markides V, Mason M, Baksi J, Pantazis A, Pennell DJ, Barton PJ, Prasad SK, Wong T, Cook SA, Ware JS.

JAMA Netw Open. 2019 Jun 5;2(6):e196520. doi: 10.1001/jamanetworkopen.2019.6520.

4.

Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy.

Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, Lunde IG, Wakimoto H, Smith AM, Toepfer CN, Getz K, Gorham J, Patel P, Ito K, Willcox JA, Arany Z, Li J, Owens AT, Govind R, Nuñez B, Mazaika E, Bayes-Genis A, Walsh R, Finkelman B, Lupon J, Whiffin N, Serrano I, Midwinter W, Wilk A, Bardaji A, Ingold N, Buchan R, Tayal U, Pascual-Figal DA, de Marvao A, Ahmad M, Garcia-Pinilla JM, Pantazis A, Dominguez F, John Baksi A, O'Regan DP, Rosen SD, Prasad SK, Lara-Pezzi E, Provencio M, Lyon AR, Alonso-Pulpon L, Cook SA, DePalma SR, Barton PJR, Aplenc R, Seidman JG, Ky B, Ware JS, Seidman CE.

Circulation. 2019 Jul 2;140(1):31-41. doi: 10.1161/CIRCULATIONAHA.118.037934. Epub 2019 Apr 16.

5.

Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy.

Walsh R, Mazzarotto F, Whiffin N, Buchan R, Midwinter W, Wilk A, Li N, Felkin L, Ingold N, Govind R, Ahmad M, Mazaika E, Allouba M, Zhang X, de Marvao A, Day SM, Ashley E, Colan SD, Michels M, Pereira AC, Jacoby D, Ho CY, Thomson KL, Watkins H, Barton PJR, Olivotto I, Cook SA, Ware JS.

Genome Med. 2019 Jan 29;11(1):5. doi: 10.1186/s13073-019-0616-z.

6.

Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield.

Thomson KL, Ormondroyd E, Harper AR, Dent T, McGuire K, Baksi J, Blair E, Brennan P, Buchan R, Bueser T, Campbell C, Carr-White G, Cook S, Daniels M, Deevi SVV, Goodship J, Hayesmoore JBG, Henderson A, Lamb T, Prasad S, Rayner-Matthews P, Robert L, Sneddon L, Stark H, Walsh R, Ware JS, Farrall M, Watkins HC; NIHR BioResource – Rare Diseases Consortium.

Genet Med. 2019 Jul;21(7):1576-1584. doi: 10.1038/s41436-018-0375-z. Epub 2018 Dec 11.

7.

Genetic Etiology for Alcohol-Induced Cardiac Toxicity.

Ware JS, Amor-Salamanca A, Tayal U, Govind R, Serrano I, Salazar-Mendiguchía J, García-Pinilla JM, Pascual-Figal DA, Nuñez J, Guzzo-Merello G, Gonzalez-Vioque E, Bardaji A, Manito N, López-Garrido MA, Padron-Barthe L, Edwards E, Whiffin N, Walsh R, Buchan RJ, Midwinter W, Wilk A, Prasad S, Pantazis A, Baski J, O'Regan DP, Alonso-Pulpon L, Cook SA, Lara-Pezzi E, Barton PJ, Garcia-Pavia P.

J Am Coll Cardiol. 2018 May 22;71(20):2293-2302. doi: 10.1016/j.jacc.2018.03.462.

8.

CardioClassifier: disease- and gene-specific computational decision support for clinical genome interpretation.

Whiffin N, Walsh R, Govind R, Edwards M, Ahmad M, Zhang X, Tayal U, Buchan R, Midwinter W, Wilk AE, Najgebauer H, Francis C, Wilkinson S, Monk T, Brett L, O'Regan DP, Prasad SK, Morris-Rosendahl DJ, Barton PJR, Edwards E, Ware JS, Cook SA.

Genet Med. 2018 Oct;20(10):1246-1254. doi: 10.1038/gim.2017.258. Epub 2018 Jan 25.

9.

Phenotype and Clinical Outcomes of Titin Cardiomyopathy.

Tayal U, Newsome S, Buchan R, Whiffin N, Halliday B, Lota A, Roberts A, Baksi AJ, Voges I, Midwinter W, Wilk A, Govind R, Walsh R, Daubeney P, Jarman JWE, Baruah R, Frenneaux M, Barton PJ, Pennell D, Ware JS, Prasad SK, Cook SA.

J Am Coll Cardiol. 2017 Oct 31;70(18):2264-2274. doi: 10.1016/j.jacc.2017.08.063.

10.

Three-dimensional cardiovascular imaging-genetics: a mass univariate framework.

Biffi C, de Marvao A, Attard MI, Dawes TJW, Whiffin N, Bai W, Shi W, Francis C, Meyer H, Buchan R, Cook SA, Rueckert D, O'Regan DP.

Bioinformatics. 2018 Jan 1;34(1):97-103. doi: 10.1093/bioinformatics/btx552.

11.

Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy.

Tayal U, Newsome S, Buchan R, Whiffin N, Walsh R, Barton PJ, Ware JS, Cook SA, Prasad SK.

J Am Coll Cardiol. 2017 May 16;69(19):2466-2468. doi: 10.1016/j.jacc.2017.03.530. No abstract available.

12.

Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes.

Walsh R, Buchan R, Wilk A, John S, Felkin LE, Thomson KL, Chiaw TH, Loong CCW, Pua CJ, Raphael C, Prasad S, Barton PJ, Funke B, Watkins H, Ware JS, Cook SA.

Eur Heart J. 2017 Dec 7;38(46):3461-3468. doi: 10.1093/eurheartj/ehw603.

13.

Histiocytoid cardiomyopathy and microphthalmia with linear skin defects syndrome: phenotypes linked by truncating variants in NDUFB11.

Rea G, Homfray T, Till J, Roses-Noguer F, Buchan RJ, Wilkinson S, Wilk A, Walsh R, John S, McKee S, Stewart FJ, Murday V, Taylor RW, Ashworth M, Baksi AJ, Daubeney P, Prasad S, Barton PJR, Cook SA, Ware JS.

Cold Spring Harb Mol Case Stud. 2017 Jan;3(1):a001271. doi: 10.1101/mcs.a001271.

14.

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis.

Alton EWFW, Armstrong DK, Ashby D, Bayfield KJ, Bilton D, Bloomfield EV, Boyd AC, Brand J, Buchan R, Calcedo R, Carvelli P, Chan M, Cheng SH, Collie DS, Cunningham S, Davidson HE, Davies G, Davies JC, Davies LA, Dewar MH, Doherty A, Donovan J, Dwyer NS, Elgmati HI, Featherstone RF, Gavino J, Gea-Sorli S, Geddes DM, Gibson JSR, Gill DR, Greening AP, Griesenbach U, Hansell DM, Harman K, Higgins TE, Hodges SL, Hyde SC, Hyndman L, Innes JA, Jacob J, Jones N, Keogh BF, Limberis MP, Lloyd-Evans P, Maclean AW, Manvell MC, McCormick D, McGovern M, McLachlan G, Meng C, Montero MA, Milligan H, Moyce LJ, Murray GD, Nicholson AG, Osadolor T, Parra-Leiton J, Porteous DJ, Pringle IA, Punch EK, Pytel KM, Quittner AL, Rivellini G, Saunders CJ, Scheule RK, Sheard S, Simmonds NJ, Smith K, Smith SN, Soussi N, Soussi S, Spearing EJ, Stevenson BJ, Sumner-Jones SG, Turkkila M, Ureta RP, Waller MD, Wasowicz MY, Wilson JM, Wolstenholme-Hogg P; on behalf of the UK Cystic Fibrosis Gene Therapy Consortium.

Southampton (UK): NIHR Journals Library; 2016 Jul.

15.

Development of a Comprehensive Sequencing Assay for Inherited Cardiac Condition Genes.

Pua CJ, Bhalshankar J, Miao K, Walsh R, John S, Lim SQ, Chow K, Buchan R, Soh BY, Lio PM, Lim J, Schafer S, Lim JQ, Tan P, Whiffin N, Barton PJ, Ware JS, Cook SA.

J Cardiovasc Transl Res. 2016 Feb;9(1):3-11. doi: 10.1007/s12265-016-9673-5. Epub 2016 Feb 17.

16.

Genetic modifiers to the PLN L39X mutation in a patient with DCM and sustained ventricular tachycardia?

Sanoudou D, Kolokathis F, Arvanitis D, Al-Shafai K, Krishnamoorthy N, Buchan RJ, Walsh R, Tsiapras D, Barton PJ, Cook SA, Kremastinos D, Yacoub M.

Glob Cardiol Sci Pract. 2015 Jul 3;2015(2):29. doi: 10.5339/gcsp.2015.29. eCollection 2015. No abstract available.

17.

ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure.

Buyandelger B, Mansfield C, Kostin S, Choi O, Roberts AM, Ware JS, Mazzarotto F, Pesce F, Buchan R, Isaacson RL, Vouffo J, Gunkel S, Knöll G, McSweeney SJ, Wei H, Perrot A, Pfeiffer C, Toliat MR, Ilieva K, Krysztofinska E, López-Olañeta MM, Gómez-Salinero JM, Schmidt A, Ng KE, Teucher N, Chen J, Teichmann M, Eilers M, Haverkamp W, Regitz-Zagrosek V, Hasenfuss G, Braun T, Pennell DJ, Gould I, Barton PJ, Lara-Pezzi E, Schäfer S, Hübner N, Felkin LE, O'Regan DP, Brand T, Milting H, Nürnberg P, Schneider MD, Prasad S, Petretto E, Knöll R.

Circ Cardiovasc Genet. 2015 Oct;8(5):643-52. doi: 10.1161/CIRCGENETICS.113.000690. Epub 2015 Jul 14.

18.

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.

Alton EWFW, Armstrong DK, Ashby D, Bayfield KJ, Bilton D, Bloomfield EV, Boyd AC, Brand J, Buchan R, Calcedo R, Carvelli P, Chan M, Cheng SH, Collie DDS, Cunningham S, Davidson HE, Davies G, Davies JC, Davies LA, Dewar MH, Doherty A, Donovan J, Dwyer NS, Elgmati HI, Featherstone RF, Gavino J, Gea-Sorli S, Geddes DM, Gibson JSR, Gill DR, Greening AP, Griesenbach U, Hansell DM, Harman K, Higgins TE, Hodges SL, Hyde SC, Hyndman L, Innes JA, Jacob J, Jones N, Keogh BF, Limberis MP, Lloyd-Evans P, Maclean AW, Manvell MC, McCormick D, McGovern M, McLachlan G, Meng C, Montero MA, Milligan H, Moyce LJ, Murray GD, Nicholson AG, Osadolor T, Parra-Leiton J, Porteous DJ, Pringle IA, Punch EK, Pytel KM, Quittner AL, Rivellini G, Saunders CJ, Scheule RK, Sheard S, Simmonds NJ, Smith K, Smith SN, Soussi N, Soussi S, Spearing EJ, Stevenson BJ, Sumner-Jones SG, Turkkila M, Ureta RP, Waller MD, Wasowicz MY, Wilson JM, Wolstenholme-Hogg P; UK Cystic Fibrosis Gene Therapy Consortium.

Lancet Respir Med. 2015 Sep;3(9):684-691. doi: 10.1016/S2213-2600(15)00245-3. Epub 2015 Jul 3. Erratum in: Lancet Respir Med. 2015 Sep;3(9):e33.

19.

Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease.

Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, Buchan RJ, Walsh R, John S, Wilkinson S, Mazzarotto F, Felkin LE, Gong S, MacArthur JA, Cunningham F, Flannick J, Gabriel SB, Altshuler DM, Macdonald PS, Heinig M, Keogh AM, Hayward CS, Banner NR, Pennell DJ, O'Regan DP, San TR, de Marvao A, Dawes TJ, Gulati A, Birks EJ, Yacoub MH, Radke M, Gotthardt M, Wilson JG, O'Donnell CJ, Prasad SK, Barton PJ, Fatkin D, Hubner N, Seidman JG, Seidman CE, Cook SA.

Sci Transl Med. 2015 Jan 14;7(270):270ra6. doi: 10.1126/scitranslmed.3010134.

20.

Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approaches.

Ware JS, John S, Roberts AM, Buchan R, Gong S, Peters NS, Robinson DO, Lucassen A, Behr ER, Cook SA.

J Cardiovasc Transl Res. 2013 Feb;6(1):94-103. doi: 10.1007/s12265-012-9401-8. Epub 2012 Sep 7.

21.

Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function.

McDermott-Roe C, Ye J, Ahmed R, Sun XM, Serafín A, Ware J, Bottolo L, Muckett P, Cañas X, Zhang J, Rowe GC, Buchan R, Lu H, Braithwaite A, Mancini M, Hauton D, Martí R, García-Arumí E, Hubner N, Jacob H, Serikawa T, Zidek V, Papousek F, Kolar F, Cardona M, Ruiz-Meana M, García-Dorado D, Comella JX, Felkin LE, Barton PJ, Arany Z, Pravenec M, Petretto E, Sanchis D, Cook SA.

Nature. 2011 Oct 5;478(7367):114-8. doi: 10.1038/nature10490.

22.

A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk.

Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, Lu H, Li Y, Sarwar R, Langley SR, Bauerfeind A, Hummel O, Lee YA, Paskas S, Rintisch C, Saar K, Cooper J, Buchan R, Gray EE, Cyster JG; Cardiogenics Consortium, Erdmann J, Hengstenberg C, Maouche S, Ouwehand WH, Rice CM, Samani NJ, Schunkert H, Goodall AH, Schulz H, Roider HG, Vingron M, Blankenberg S, Münzel T, Zeller T, Szymczak S, Ziegler A, Tiret L, Smyth DJ, Pravenec M, Aitman TJ, Cambien F, Clayton D, Todd JA, Hubner N, Cook SA.

Nature. 2010 Sep 23;467(7314):460-4. doi: 10.1038/nature09386. Epub 2010 Sep 8.

23.

MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.

Lu H, Buchan RJ, Cook SA.

Cardiovasc Res. 2010 Jun 1;86(3):410-20. doi: 10.1093/cvr/cvq010. Epub 2010 Jan 15.

PMID:
20080987
24.

Measuring success in a pesticide risk reduction program among migrant farmworkers in Colorado.

Vela Acosta MS, Chapman P, Bigelow PL, Kennedy C, Buchan RM.

Am J Ind Med. 2005 Mar;47(3):237-45.

PMID:
15712260
25.

Cold blast furnace syndrome: a new source of toxic inhalation by nitrogen oxides.

Tague I, Llewellin P, Burton K, Buchan R, Yates DH.

Occup Environ Med. 2004 May;61(5):461-3.

26.

Determination of large aerosol particle size by elutriation.

Tillery M, Buchan R.

Appl Occup Environ Hyg. 2002 Oct;17(10):717-22.

PMID:
12363213
27.

Assessment of occupational health and safety risks of farmworkers in Colorado.

Vela-Acosta MS, Bigelow P, Buchan R.

Am J Ind Med. 2002 Aug;Suppl 2:19-27.

PMID:
12210678
28.

Total dust, respirable dust, and microflora toxin concentrations in Colorado corn storage facilities.

Todd BE, Buchan RM.

Appl Occup Environ Hyg. 2002 Jun;17(6):411-5.

PMID:
12049430
29.

Evaluation of airborne dust and endotoxin in corn storage and processing facilities in Colorado.

Buchan RM, Rijal P, Sandfort D, Keefe T.

Int J Occup Med Environ Health. 2002;15(1):57-64.

PMID:
12038866
30.

Acute respiratory effects and endotoxin exposure during wheat harvest in Northeastern Colorado.

Viet SM, Buchan R, Stallones L.

Appl Occup Environ Hyg. 2001 Jun;16(6):685-97.

PMID:
11414519
31.

Field evaluation of a portable photoionization detector for assessing exposure to solvent mixtures.

Coy JD, Bigelow PL, Buchan RM, Tessari JD, Parnell JO.

AIHAJ. 2000 Mar-Apr;61(2):268-74.

PMID:
10782199
32.

Exposures of geotechnical laboratory workers to respirable crystalline silica.

Miller SK, Bigelow PL, Sharp-Geiger R, Buchan RM.

Appl Occup Environ Hyg. 1999 Jan;14(1):39-44.

PMID:
10730137
33.

Misery perfusion with preserved vascular reactivity in Alzheimer's disease.

Nagata K, Buchan RJ, Yokoyama E, Kondoh Y, Sato M, Terashi H, Satoh Y, Watahiki Y, Senova M, Hirata Y, Hatazawa J.

Ann N Y Acad Sci. 1997 Sep 26;826:272-81.

PMID:
9329699
34.

Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type.

Buchan RJ, Nagata K, Yokoyama E, Langman P, Yuya H, Hirata Y, Hatazawa J, Kanno I.

Electroencephalogr Clin Neurophysiol. 1997 Sep;103(3):409-17.

PMID:
9305290
35.

Scalp topography of SEP late components in patients with supra-tentorial lesions.

Yuya H, Nagata K, Takanashi Y, Satoh Y, Watahiki Y, Hirata Y, Yokoyama E, Buchan RJ.

Brain Topogr. 1996 Spring;8(3):333-6.

PMID:
8728428
36.

A local exhaust ventilation system to reduce airborne ribavirin concentrations.

Matlock D, Buchan RM, Tillery M.

Am Ind Hyg Assoc J. 1991 Oct;52(10):428-32.

PMID:
1951053
37.

Glucosyltransferase production by Streptococcus sanguis Challis and comparison with other oral streptococci.

Buchan RA, Jenkinson HF.

Oral Microbiol Immunol. 1990 Apr;5(2):63-71.

PMID:
2150879
38.

The position of the personal dosemeter in diagnostic X-ray practice.

Buchan RC.

Br J Radiol. 1987 Jul;60(715):728. No abstract available.

PMID:
3620838
39.

A predictive model for determining asbestos concentrations for fibers less than five micrometers in length.

Kiefer MJ, Buchan RM, Keefe TJ, Blehm KD.

Environ Res. 1987 Jun;43(1):31-8.

PMID:
3034564
40.

The determination of ambient air quality within an environmental care unit.

Belger AL, Blehm KD, Buchan RM.

J Environ Health. 1987 Mar-Apr;49(5):288-93.

PMID:
10281781
41.

Effect of waste anesthetic gas and vapor exposure on reproductive outcome in veterinary personnel.

Johnson JA, Buchan RM, Reif JS.

Am Ind Hyg Assoc J. 1987 Jan;48(1):62-6.

PMID:
3565261
42.

Characterization of particleboard aerosol--size distribution and formaldehyde content.

Stumpf JM, Blehm KD, Buchan RM, Gunter BJ.

Am Ind Hyg Assoc J. 1986 Dec;47(12):725-30.

PMID:
3799471
43.

Aerosol sampling efficiency of 37 mm filter cassettes.

Buchan RM, Soderholm SC, Tillery MI.

Am Ind Hyg Assoc J. 1986 Dec;47(12):825-31. Erratum in: Am Ind Hyg Assoc J 1987 May;48(5):A-333.

PMID:
3593471
44.

Airborne asbestos in Colorado public schools.

Chadwick DA, Buchan RM, Beaulieu HJ.

Environ Res. 1985 Feb;36(1):1-13.

PMID:
3881254
45.

The accreditation of academic programs in industrial hygiene.

Cudworth AL, Craft BF, Bohl CD, Buchan RM, Garber BT, Kornreich LD, Levin L, Peterson JE.

Am Ind Hyg Assoc J. 1984 Oct;45(10):A6-8.

PMID:
6496313
46.

Development of a mathematical model for predicting concentrations of small asbestos fibers.

Buchan RM, Richardson DC, Beaulieu HJ, Keefe TJ.

Environ Res. 1984 Apr;33(2):296-9.

PMID:
6370673
47.

Asbestos in Colorado schools.

Baldwin CA, Beaulieu HJ, Buchan RM, Johnson HH.

Public Health Rep. 1982 Jul-Aug;97(4):325-31.

48.

Acute toxicity of an in situ shale oil process wastewater and its major components to Daphnia magna.

Burnham LN, Melvin WW, Buchan RM.

Bull Environ Contam Toxicol. 1981 Sep;27(3):338-43. No abstract available.

PMID:
7296068
49.

Characterization of the aerosol in turkey rearing confinements.

Cravens RL, Beaulieu HJ, Buchan RM.

Am Ind Hyg Assoc J. 1981 Apr;42(4):315-8.

PMID:
7234689
50.

Waste anesthetic gas exposures to veterinarians and animal technicians.

Wingfield WE, Ruby DL, Buchan RM, Gunther BJ.

J Am Vet Med Assoc. 1981 Feb 15;178(4):399-402.

PMID:
7195390

Supplemental Content

Loading ...
Support Center